Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure
Top Cited Papers
- 24 May 2002
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 39 (11) , 1780-1786
- https://doi.org/10.1016/s0735-1097(02)01854-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summaryJournal of the American College of Cardiology, 2001
- Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunctionJournal of the American College of Cardiology, 2001
- The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyJournal of the American College of Cardiology, 2001
- The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsPublished by Elsevier ,2000
- Risk stratification in chronic heart failurePublished by Oxford University Press (OUP) ,1998
- Impact of a Comprehensive Heart Failure Management Program on Hospital Readmission and Functional Status of Patients With Advanced Heart FailureJournal of the American College of Cardiology, 1997
- Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease managementAmerican Heart Journal, 1997
- The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal diseasePublished by Elsevier ,1996
- A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart FailureNew England Journal of Medicine, 1995
- Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathyThe American Journal of Cardiology, 1990